Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Conversation logo

In June 2019, a paper by prominent US academics found that people who used e-cigarettes were at greater risk of a heart attack. The authors concluded that e-cigarettes were just as risky as tobacco in provoking heart attacks, and that using e-cigarettes and traditional cigarettes at the same time was even riskier. Unsurprisingly, this caused a stir in the media – in the form of 35 news stories, to be exact. Also unsurprisingly, it provoked vigorous scientific debate. Eight months later, the paper was retracted.

When a paper is retracted it means we can’t trust its results. It’s like being unpublished. The problem is, the paper still exists – it’s in news stories, it’s on social media, it’s in documentaries. Smokers see these stories and increasingly think e-cigarettes are as harmful as smoking. That’s a problem because smoking is deadly.

Read the full article on The Conversation website, written by Jamie Hartmann-Boyce, Senior Researcher (Nuffield Department of Primary Health Care Sciences)

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

 

 

 

Similar stories

RECOVERY trial team awarded MRC Impact Prize for Outstanding Team Impact

The Medical Research Council Prize Committee has awarded the RECOVERY trial team the MRC Impact Prize 2022 for Outstanding Team Impact.

Professor Sir Chris Whitty brings greater understanding of epidemics to Oxford

Chief Medical Officer of England Professor Sir Chris Whitty KCB FMedSci delivers the Sherrington Prize Lecture: Public Understanding of Science to an audience of Oxford staff and students.

Multiple Debilitating Pains – New global study shows the experience of Endometriosis is rooted in a person’s genetics

Researchers at the University of Oxford in collaboration with 25 teams across the world have published the largest study to date of the genetic basis of endometriosis.

Study shows delaying treatment for localised prostate cancer does not increase mortality risk

Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind.

Showcasing Oxford’s translational research for Rare Disease Day

Rare Disease Day is an annual awareness day that aims to educate and raise awareness for the 400 million people worldwide who live with a rare disease.

Prostate cancer AI diagnosis tool begins evaluation in Oxford

New artificial intelligence software that can help to spot prostate cancer is being trialled by researchers at Oxford University Hospitals (OUH) NHS Foundation Trust.